Article
Recent advances in the molecular understanding of glioblastoma.
Journal of neuro-oncology - 1 May 2012
Bleeker Fonnet E, Molenaar Remco J, Leenstra Sieger
Abstract excerpt
Glioblastoma is the most common and most aggressive primary brain tumor. Despite maximum treatment, patients only have a median survival time of 15 months, because of the tumor's resistance to current therapeutic approaches. Thus far, methylation of the O (6)-methylguanine-DNA methyltransferase (MGMT) promoter has been the only confirmed molecular predictive factor in glioblastoma. Novel "genome-wide" techniques...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
